% | $
Quotes you view appear here for quick access.

QLT Inc. Message Board

  • ttotoole ttotoole Nov 2, 1999 3:26 PM Flag


    Gilead was supposed to have a slam dunk today
    with FDA advisory panel for adefovir(HIV/Hepatitis
    Tx). Denied 13-1. There are no sure things. Adeforvir
    had fast-track status, CEO was promising the world.
    No sure things in this world. November 17th will
    tell the story. I was surprised there wasn't more
    press surruonding the last ophthamology conference.
    Will deifinitey wait till after the advisory panel
    meets to add to my position.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • ttotoole summed up what's going on here: down in
      sympathy with Gilead getting hammered. The concern with
      Gilead, by the way, was patient safety, not efficacy, so
      the stories clearly aren't parallel on any

      Personally, I'd like to see this thing go lower so I can get
      in before the FDA.



1.420.00(0.00%)Aug 29 4:00 PMEDT